Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Atlas Venture Associates IX, LLC (CIK 1780067) reported $631.0M across 7 reported positions in its SEC 13F filing for 2020-12-31. Largest positions: SKLZ ($465.7M, 73.80%), NTLA ($87.9M, 13.93%), SURF ($27.2M, 4.31%), SPRO ($26.7M, 4.23%), COGT ($10.3M, 1.63%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SKLZ | SKILLZ INC | $465.7M | 73.80% | 23.3M | New |
| 2 | NTLA | INTELLIA THERAPEUTICS INC | $87.9M | 13.93% | 1.6M | New |
| 3 | SURF | SURFACE ONCOLOGY INC | $27.2M | 4.31% | 2.9M | New |
| 4 | SPRO | SPERO THERAPEUTICS INC | $26.7M | 4.23% | 1.4M | New |
| 5 | COGT | COGENT BIOSCIENCES INC | $10.3M | 1.63% | 916,196 | New |
| 6 | SNAP | SNAP INC | $7.5M | 1.19% | 150,160 | New |
| 7 | SYBX | SYNLOGIC INC | $5.7M | 0.91% | 2.7M | New |
Source: SEC Form 13F filings · as of 2020-12-31